We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+15.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.93B
AUM Growth
+$1.24B
(+22%)
Cap. Flow
+$454M
Cap. Flow
% of AUM
6.54%
Top 10 Holdings %
Top 10 Hldgs %
16.4%
Holding
1,110
New
146
Increased
497
Reduced
266
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVR
NVR
|
+$34.9M |
| 2 |
SBA Communications
SBAC
|
+$31.5M |
| 3 |
Lennox International
LII
|
+$29.1M |
| 4 |
McKesson
MCK
|
+$24.8M |
| 5 |
Cable One
CABO
|
+$23.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.8M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$42.5M |
| 4 |
Intuitive Surgical
ISRG
|
+$35.5M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 16.58% |
| 3 | Consumer Discretionary | 13.8% |
| 4 | Industrials | 12.36% |
| 5 | Healthcare | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Molina Healthcare
MOH
$10.3B
| $13.9M | 0.2% |
97,965
-48,110
| -33% | -$6.51M |
|
127
Gilead Sciences
GILD
$161B
| $13.9M | 0.2% |
213,890
+189,460
| +776% | +$12.6M |
|
128
Lincoln Electric
LECO
$13.8B
| $13.7M | 0.2% |
163,624
+20,820
| +15% | +$1.77M |
|
|
MDRX
129
DELISTED
Veradigm Inc. Common Stock
MDRX
| $13.7M | 0.2% |
1,435,739
+92,400
| +7% | +$1.02M |
|
130
Bank of N.T. Butterfield & Son
NTB
$2.42B
| $13.5M | 0.2% |
377,506
+81,720
| +28% | +$2.94M |
|
131
Viavi Solutions
VIAV
$9.75B
| $13.5M | 0.2% |
1,091,359
-357,785
| -25% | -$4.19M |
|
132
NOV
NOV
$7.45B
| $13.3M | 0.19% |
499,430
-176,380
| -26% | -$5M |
|
133
US Foods
USFD
$21.4B
| $13.3M | 0.19% |
380,672
+194,120
| +104% | +$6.66M |
|
134
Ryder
R
$10.3B
| $13.3M | 0.19% |
213,857
-72,061
| -25% | -$4.22M |
|
135
Rollins
ROL
$18.6B
| $13.2M | 0.19% |
475,950
+53,085
| +13% | +$1.38M |
|
136
Bunge Global
BG
$23.6B
| $13.1M | 0.19% |
247,699
+124,900
| +102% | +$6.63M |
|
137
HF Sinclair
DINO
$15.9B
| $13M | 0.19% |
263,135
+21,550
| +9% | +$1.15M |
|
138
Douglas Emmett
DEI
$2.06B
| $12.7M | 0.18% |
314,370
-41,611
| -12% | -$1.58M |
|
139
Synchrony
SYF
$23.7B
| $12.6M | 0.18% |
394,080
+68,120
| +21% | +$2.05M |
|
140
Nexstar Media Group
NXST
$5.6B
| $12.5M | 0.18% |
+115,109
| New | +$10.6M |
|
141
Peabody Energy
BTU
$2.78B
| $12.4M | 0.18% |
436,914
+108,218
| +33% | +$3.41M |
|
142
First Bancorp
FBP
$4.4B
| $12.3M | 0.18% |
1,076,878
+132,418
| +14% | +$1.4M |
|
143
Teradata
TDC
$2.68B
| $12.2M | 0.18% |
279,782
+20,960
| +8% | +$941K |
|
144
Raymond James Financial
RJF
$32.5B
| $12.2M | 0.18% |
227,594
+14,235
| +7% | +$762K |
|
|
TSE
145
DELISTED
Trinseo
TSE
| $12.2M | 0.18% |
269,203
+48,840
| +22% | +$2.36M |
|
146
Coca-Cola Consolidated
COKE
$12.3B
| $12.2M | 0.18% |
423,320
+125,760
| +42% | +$2.87M |
|
147
NXP Semiconductors
NXPI
$68B
| $12.2M | 0.18% |
+137,470
| New | +$12.1M |
|
148
Bloomin' Brands
BLMN
$680M
| $12.1M | 0.17% |
592,025
+392,427
| +197% | +$7.81M |
|
149
General Motors
GM
$74.7B
| $12M | 0.17% |
323,469
+210,140
| +185% | +$7.98M |
|
150
KBR
KBR
$4.68B
| $11.9M | 0.17% |
623,090
-47,855
| -7% | -$864K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2019 Portfolio in Review
As of Q1 2019, Jacobs Levy Equity Management held 1,110 positions worth $6.93B, up 22% from $5.69B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $454M of net new capital in Q1 2019, opening 146 new positions and adding to 497 existing holdings. Its largest new stake was AbbVie: 282,010 shares worth $22.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $52.7M trimmed.
- Jacobs Levy Equity Management's largest Q1 2019 buy was AbbVie: 282,010 shares worth $22.7M.
- Jacobs Levy Equity Management added most to NVR in Q1 2019, an estimated $34.9M increase.
- Jacobs Levy Equity Management's biggest Q1 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $52.7M.
- Jacobs Levy Equity Management fully exited Celgene Corp in Q1 2019, selling an estimated $55.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $6.93B portfolio in Q1 2019.
- Jacobs Levy Equity Management opened 146 new positions and closed 160 in Q1 2019.
- Jacobs Levy Equity Management's portfolio value rose 22% quarter-over-quarter to $6.93B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2019, filed 14 May 2019.